| Lactose (India) Ltd | 138 Cr. | 109 | 247/84.3 | 30.5 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.36 Cr. | 1.76 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,347 Cr. | 399 | 479/192 | 90.0 | 24.3 | 0.17 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 33.1 Cr. | 44.6 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 43.8 Cr. | 29.9 | 30.5/17.0 | 104 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 56.4 Cr. | 75.0 | 134/73.2 | 15.2 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 55,478 Cr. | 1,966 | 2,286/1,275 | 22.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 341 Cr. | 14.0 | 19.0/10.8 | 20.4 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 19.2/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 890 Cr. | 1,885 | 1,999/635 | 30.8 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 93.6 Cr. | 18.7 | 32.0/17.0 | 25.6 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 793 Cr. | 269 | 449/219 | 7.08 | 133 | 0.93 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.84 Cr. | 3.15 | 9.28/2.11 | 4.45 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 404 Cr. | 416 | 477/142 | 61.1 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,583 Cr. | 1,051 | 1,565/1,022 | 41.5 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.12/0.26 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 41.4 Cr. | 15.7 | 26.3/6.88 | 20.2 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.59 Cr. | 9.49 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 169 Cr. | 473 | 859/443 | 9.56 | 596 | 0.32 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 75.3 Cr. | 75.3 | 92.5/26.1 | 142 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,742 Cr. | 1,405 | 2,452/1,345 | 45.8 | 174 | 0.76 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.2 Cr. | 42.1 | 88.7/36.1 | 41.8 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 14.0 Cr. | 5.62 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.5 Cr. | 110 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 57.6 Cr. | 105 | 105/9.41 | 39.7 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 26.4 Cr. | 35.0 | 80.0/35.0 | 42.6 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.77 Cr. | 19.2 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,875 Cr. | 569 | 1,028/492 | 28.0 | 72.4 | 0.21 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.2 Cr. | 20.2 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.4 Cr. | 22.4 | 43.7/17.4 | 49.4 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 91,057 Cr. | 2,206 | 3,055/2,115 | 54.6 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 213 Cr. | 370 | 524/241 | 21.9 | 123 | 1.22 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 58.8 Cr. | 40.9 | 62.6/26.7 | 91.8 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,138 Cr. | 1,209 | 1,365/994 | 20.5 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 159 Cr. | 256 | 303/159 | 152 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 806 Cr. | 79.9 | 123/74.0 | 20.8 | 32.6 | 1.88 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.3 Cr. | 29.3 | 50.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,198 Cr. | 1,735 | 1,902/919 | 63.4 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.45/0.55 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 213 Cr. | 27.8 | 68.0/27.1 | 13.6 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 4.45 Cr. | 7.60 | 23.6/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 130 Cr. | 5.52 | 6.57/2.82 | 302 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 61,403 Cr. | 28,890 | 37,000/25,260 | 40.7 | 1,888 | 1.64 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,420 Cr. | 708 | 972/550 | 26.8 | 226 | 0.71 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 213 Cr. | 77.4 | 100/31.3 | 59.5 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,960 Cr. | 1,619 | 1,740/603 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,998 Cr. | 1,415 | 1,870/1,110 | 419 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 829 Cr. | 240 | 330/154 | 19.3 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,033 Cr. | 771 | 800/270 | 16.3 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,183 Cr. | 451 | 843/438 | 21.8 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,529 Cr. | 1,087 | 1,595/991 | 21.6 | 768 | 0.92 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,25,908 Cr. | 3,721 | 3,882/2,886 | 58.1 | 250 | 0.86 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 958 Cr. | 104 | 298/98.0 | | 41.3 | 0.48 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,443 Cr. | 15.4 | 24.0/14.1 | 23.0 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,777 Cr. | 544 | 1,342/541 | 60.5 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,932 Cr. | 173 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,33,837 Cr. | 1,807 | 1,910/1,547 | 37.6 | 324 | 0.89 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,466 Cr. | 558 | 839/441 | 385 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,000 Cr. | 320 | 335/175 | 37.0 | 81.2 | 0.12 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,543 Cr. | 335 | 502/265 | 42.3 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,378 Cr. | 213 | 260/111 | 124 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,128 Cr. | 4,399 | 6,718/4,146 | 27.4 | 340 | 2.66 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,672 Cr. | 2,211 | 2,725/1,772 | 32.9 | 335 | 0.90 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,679 Cr. | 5,833 | 6,739/4,904 | 31.6 | 373 | 2.14 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 176 Cr. | 50.0 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,764 Cr. | 4,972 | 5,993/3,701 | 32.2 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 106 Cr. | 86.3 | 250/81.0 | 11.0 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,149 Cr. | 350 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,328 Cr. | 853 | 1,998/604 | 82.8 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 21,783 Cr. | 16,974 | 19,748/10,060 | 111 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 403 Cr. | 17.9 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,738 Cr. | 935 | 1,505/660 | 10.9 | 483 | 0.64 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,337 Cr. | 42.7 | 91.7/41.7 | 30.9 | 21.8 | 0.47 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,626 Cr. | 190 | 359/162 | 24.5 | 59.3 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 38.2 Cr. | 24.3 | 130/23.9 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 297 Cr. | 83.6 | 177/78.0 | 145 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 94,977 Cr. | 2,080 | 2,403/1,774 | 22.0 | 430 | 0.58 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,008 Cr. | 503 | 980/490 | 12.6 | 357 | 0.36 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,900 Cr. | 1,016 | 1,040/501 | 80.4 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 940 Cr. | 906 | 1,235/596 | 19.1 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 139 Cr. | 64.5 | 116/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 679 Cr. | 141 | 227/123 | 38.5 | 104 | 2.13 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 594 Cr. | 341 | 500/265 | 21.6 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,259 Cr. | 1,080 | 1,265/802 | 34.7 | 414 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 27,630 Cr. | 1,764 | 1,952/1,303 | 38.5 | 243 | 0.88 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,433 Cr. | 216 | 302/193 | 32.7 | 38.0 | 1.16 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,653 Cr. | 1,444 | 1,758/1,168 | 37.0 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,550 Cr. | 86.9 | 127/57.5 | 22.0 | 59.7 | 0.92 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 768 Cr. | 94.8 | 124/67.2 | 25.9 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,364 Cr. | 255 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,995 Cr. | 244 | 457/217 | 297 | 96.9 | 0.57 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,398 Cr. | 1,642 | 2,674/1,243 | 31.9 | 397 | 0.43 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,518 Cr. | 351 | 498/285 | 64.8 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,787 Cr. | 568 | 621/412 | 27.0 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 55,454 Cr. | 1,966 | 2,286/1,275 | 22.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,725 Cr. | 2,519 | 3,516/1,921 | 44.8 | 101 | 1.67 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 29,154 Cr. | 1,771 | 2,131/1,200 | 25.2 | 610 | 1.02 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,727 Cr. | 413 | 530/359 | 29.8 | 149 | 1.21 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,174 Cr. | 1,561 | 1,910/1,097 | 50.9 | 227 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,06,798 Cr. | 1,281 | 1,406/1,020 | 18.5 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,706 Cr. | 237 | 322/178 | 24.8 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,808 Cr. | 1,508 | 1,673/1,310 | 22.4 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,329 Cr. | 1,888 | 2,641/1,551 | 24.3 | 416 | 0.32 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 290 Cr. | 98.9 | 203/95.2 | 20.8 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,634 Cr. | 155 | 191/105 | 14.9 | 107 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 54.4 Cr. | 33.6 | 68.5/32.6 | 19.1 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 54,658 Cr. | 410 | 425/291 | 115 | 200 | 0.12 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,707 Cr. | 1,691 | 2,190/1,430 | 37.7 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 117 Cr. | 73.8 | 132/73.0 | 17.2 | 49.2 | 1.63 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 341 Cr. | 148 | 205/67.8 | 32.2 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,804 Cr. | 9,118 | 10,691/6,301 | 98.6 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,934 Cr. | 668 | 843/544 | 34.1 | 118 | 0.69 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 183 Cr. | 86.7 | 137/75.2 | 9.70 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,499 Cr. | 5,648 | 5,868/4,492 | 28.7 | 1,116 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,867 Cr. | 910 | 1,124/725 | 28.2 | 271 | 1.21 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 442 Cr. | 780 | 1,540/763 | | 690 | 0.64 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 32,568 Cr. | 2,607 | 3,116/2,022 | 33.4 | 345 | 1.07 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,508 Cr. | 314 | 412/258 | 23.8 | 133 | 1.66 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,748 Cr. | 411 | 575/312 | 19.7 | 147 | 0.24 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,566.25 Cr | 1,174.15 | | 52.64 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |